Liang Lin

2.0k total citations
76 papers, 1.6k citations indexed

About

Liang Lin is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Liang Lin has authored 76 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 24 papers in Molecular Biology and 19 papers in Oncology. Recurrent topics in Liang Lin's work include Multiple Myeloma Research and Treatments (25 papers), CAR-T cell therapy research (11 papers) and Cardiac and Coronary Surgery Techniques (8 papers). Liang Lin is often cited by papers focused on Multiple Myeloma Research and Treatments (25 papers), CAR-T cell therapy research (11 papers) and Cardiac and Coronary Surgery Techniques (8 papers). Liang Lin collaborates with scholars based in China, United States and Taiwan. Liang Lin's co-authors include Lijie Xing, Shih‐Feng Cho, Kenneth C. Anderson, Yu‐Tzu Tai, Tengteng Yu, Xing Chen, Kenneth Wen, Senlian Hong, Nikhil C. Munshi and Adam Sampson-Johannes and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Blood.

In The Last Decade

Liang Lin

72 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liang Lin China 24 534 463 353 307 187 76 1.6k
Sanjay Tiwari Germany 20 509 1.0× 336 0.7× 298 0.8× 222 0.7× 116 0.6× 75 1.6k
Maria Palmisano United States 23 503 0.9× 385 0.8× 345 1.0× 174 0.6× 63 0.3× 85 1.5k
Ulrich Beyer Switzerland 27 672 1.3× 533 1.2× 670 1.9× 135 0.4× 189 1.0× 49 2.4k
David M. Weinreich United States 20 685 1.3× 453 1.0× 115 0.3× 576 1.9× 171 0.9× 32 2.8k
Claude Linassier France 28 786 1.5× 738 1.6× 348 1.0× 170 0.6× 89 0.5× 97 2.7k
Michael H. Creer United States 30 1.2k 2.2× 385 0.8× 417 1.2× 199 0.6× 163 0.9× 69 2.4k
Hongyan Xu United States 21 678 1.3× 229 0.5× 106 0.3× 220 0.7× 247 1.3× 93 1.6k
Dengfeng Cheng China 24 740 1.4× 287 0.6× 95 0.3× 164 0.5× 541 2.9× 125 2.1k
Bingbing Yang China 22 339 0.6× 990 2.1× 298 0.8× 240 0.8× 205 1.1× 84 1.9k
Kersten Peldschus Germany 15 452 0.8× 229 0.5× 75 0.2× 70 0.2× 180 1.0× 34 2.1k

Countries citing papers authored by Liang Lin

Since Specialization
Citations

This map shows the geographic impact of Liang Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang Lin more than expected).

Fields of papers citing papers by Liang Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liang Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang Lin. The network helps show where Liang Lin may publish in the future.

Co-authorship network of co-authors of Liang Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Liang Lin. A scholar is included among the top collaborators of Liang Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liang Lin. Liang Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pu, Yunfei, Yiming Zhao, H.Q. Ye, et al.. (2025). ART: Anonymous Region Transformer for Variable Multi-Layer Transparent Image Generation. 7952–7962. 1 indexed citations
2.
Xing, Wen, et al.. (2023). Abnormal changes of bone metabolism markers with age in children with cerebral palsy. Frontiers in Pediatrics. 11. 1214608–1214608. 2 indexed citations
3.
Huang, Xiaopeng, Jinshan Zhang, Yongqiang Zheng, et al.. (2023). Alcoholic drink produced by pea is a risk factor for incident knee surgery in patients with knee osteoarthritis. Frontiers in Nutrition. 10. 1264338–1264338. 2 indexed citations
4.
Wu, Xiang, Stella Chariton, Vitali B. Prakapenka, et al.. (2022). Experimental Constraints on the Fate of Subducted Sedimentary Nitrogen in the Reduced Mantle. Journal of Geophysical Research Solid Earth. 127(12). 1 indexed citations
6.
Xing, Lijie, Su Wang, Jiye Liu, et al.. (2021). BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression. Clinical Cancer Research. 27(19). 5376–5388. 22 indexed citations
7.
Tang, Cheng, Liang Lin, Xiaojun Zhu, et al.. (2021). Theoretical and experimental Raman study of molybdenum disulfide. Journal of Physics and Chemistry of Solids. 156. 110154–110154. 1 indexed citations
8.
Lin, Liang, Shih‐Feng Cho, Lijie Xing, et al.. (2020). Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma. Leukemia. 35(3). 752–763. 64 indexed citations
9.
Lin, Chenlu, et al.. (2020). Color and genesis of californite from Pakistan: insights from μ-XRF mapping, optical spectra and X-ray photoelectron spectroscopy. Scientific Reports. 10(1). 285–285. 9 indexed citations
11.
Pearce, Fiona, et al.. (2018). Health Technology Assessment and Its Use in Drug Policies: Singapore. Value in Health Regional Issues. 18. 176–183. 22 indexed citations
12.
Cho, Shih‐Feng, Liang Lin, Lijie Xing, et al.. (2018). Anti-BCMA BiTE® AMG 701 Potently Induces Specific T Cell Lysis of Human Multiple Myeloma (MM) Cells and Immunomodulation in the Bone Marrow Microenvironment. Blood. 132(Supplement 1). 592–592. 23 indexed citations
14.
Lin, Liang, Lijie Xing, Chirag Acharya, et al.. (2017). CD8+ Anti-BCMA mRNA CAR T-Cells Effectively Kill Human Multiple Myeloma Cells In Vitro and In Vivo. Blood. 130. 3067–3067. 6 indexed citations
15.
Cho, Shih‐Feng, Liang Lin, Lijie Xing, et al.. (2017). Monoclonal Antibody: A New Treatment Strategy against Multiple Myeloma. Antibodies. 6(4). 18–18. 11 indexed citations
16.
Lin, Liang, Yan Fan, Dandan Zhao, et al.. (2016). Reelin promotes the adhesion and drug resistance of multiple myeloma cells via integrin β1 signaling and STAT3. Oncotarget. 7(9). 9844–9858. 39 indexed citations
17.
Lin, Liang, Wee Shiong Lim, Hui Zhou, et al.. (2015). Clinical and Safety Outcomes of Oral Antithrombotics for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Network Meta-analysis. Journal of the American Medical Directors Association. 16(12). 1103.e1–1103.e19. 44 indexed citations
18.
Xu, Xi, Rong Jin, Ke Wang, et al.. (2014). Retention and tolerance of autoreactive CD4+ recent thymic emigrants in the liver. Journal of Autoimmunity. 56. 87–97. 8 indexed citations
19.
Lin, Liang, Ying Zhao, Paul Chew, et al.. (2014). Comparative Efficacy and Tolerability of Topical Prostaglandin Analogues for Primary Open-Angle Glaucoma and Ocular Hypertension. Annals of Pharmacotherapy. 48(12). 1585–1593. 41 indexed citations
20.
Lin, Liang, Xiangdong Tian, Senlian Hong, et al.. (2013). A Bioorthogonal Raman Reporter Strategy for SERS Detection of Glycans on Live Cells. Angewandte Chemie International Edition. 52(28). 7266–7271. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026